Huntington's disease is a neurodegenerative disorder characterized by the selective loss of
striatal neurons and, to a lesser extent, cortical neurons. The neurodegenerative process is …

Oxidative stress and loss of neurotrophic support play major roles in the development of
various diseases of the central and peripheral nervous systems. In disorders of the central …

There is no satisfactory treatment for Huntington's disease (HD), a hereditary
neurodegenerative disorder that produces chorea, dementia, and death. One potential …

Neurotrophic factors (NTFs) represent one of the most stimulating challenge in
neurodegenerative diseases, due to their potential in neurorestoring and neuroprotection …

INTRODUCTION: Huntington's disease (HD) is a neurodegenerative genetic disorder
caused by expansion of polyglutamine repeats in the huntingtin gene and characterised by …

Abstract Spinocerebellar ataxia type 3 (SCA3), or Machado–Joseph disease (MJD), is an
autosomal dominant neurodegenerative disorder caused by the expansion of a …

Background: Starting from the chemical structure of phytocannabinoids, isolated from
Cannabis sativa plant, research groups designed numerous cannabimimetic drugs. These …

The present invention relates to cannabinoids for use in the prevention or treatment of
neurodegenerative diseases or disorders. Preferably the cannabinoids are …

We have shown previously that application of fibroblast growth factor-2 (FGF-2) to the cut
optic nerve of the frog, Rana pipiens, augments the survival of retinal ganglion cells (RGCs) …

Résumé La maladie de Huntington (MH) est une maladie neurodégénérative génétique qui
se caractérise par des déficits moteurs ainsi que des troubles cognitifs et psychiatriques …